Berkeley Lovelace Jr. is a health and medical news reporter for NBC News.
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months. Zepbound is the latest entrant into the field of powerful new drugs that already includes Novo Nordisk’s Ozempic and Wegovy and Lilly’s Mounjaro. The FDA approved the drug for adults with obesity or who are overweight with at least one weight-related condition.
“When I’m talking to a patient, I’m going to discuss both of them,” he said. The new drug, like others in its class, comes with side effects including gastrointestinal problems. Dr. Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinic, said that while gastrointestinal issues are very common with GLP-1 medications, most of the side effects will not affect a person’s quality of life.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
US FDA approves Lilly weight-loss drug, will compete with Novo's WegovyUS FDA approves Lilly weight-loss drug, will compete with Novo's Wegovy
Consulte Mais informação »
FDA approves new version of diabetes drug Mounjaro for weight loss under a new nameIt's the latest diabetes drug approved for weight loss.
Consulte Mais informação »
FDA approves new version of diabetes drug Mounjaro for weight lossSetting—and sticking to—a holiday budget could help you avoid finical hardship down the road.
Consulte Mais informação »
FDA approves new version of Eli Lilly diabetes drug for weight lossThere's a unique therapy option for Hoosiers with disabilities or who are battling a mental health challenge.
Consulte Mais informação »
FDA approves new version of diabetes drug Mounjaro for weight lossEven though multiple suspects have been captured on camera, so far police haven't been able to catch the crooks.
Consulte Mais informação »
FDA approves new diabetes drug Mounjaro for weight lossA new diabetes drug has been approved by the US Food and Drug Administration for use as a weight-loss drug.
Consulte Mais informação »